Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.
Liver Int. 2012 Jul;32(6):937-44. doi: 10.1111/j.1478-3231.2011.02749.x. Epub 2012 Jan 20.
BACKGROUND/AIMS: Serum alanine aminotransferase (ALT) is an easily available, low-cost screening tool for detecting silent chronic liver disease. Recent studies have suggested that the currently accepted healthy ALT thresholds be lowered.
In this retrospective cross-sectional study, we determined upper thresholds for ALT values in a nationally representative healthy cohort (n = 3337) from the Fourth Korea National Health and Nutrition Examination Survey (KNHANES IV). Sensitivity and specificity of the currently used ALT threshold (40 IU/L, regardless of gender) was compared against study-derived, gender-specific ALT thresholds for detecting individuals at risk for chronic liver disease in 27 913 health check-up participants.
The 95th percentile levels for ALT in healthy weight, metabolically normal, liver disease-free KNHANES participants were 34 IU/L for men and 25 IU/L for women. The prevalence of ALT elevation among health check-up participants was 11.0% in currently used thresholds, and increased to 22.6% with study-derived, gender-specific thresholds. Of the population who were additionally defined to have elevated ALT levels under new ALT threshold, 65.7% were at risk for chronic liver disease. Sensitivity for detecting individuals at risk for chronic liver disease improved from 18 to 33% with new thresholds whereas a trade-off in specificity (from 96 to 88%) was observed.
It is recommendable to lower the current ALT thresholds to better identify individuals at risk for chronic liver disease.
背景/目的:血清丙氨酸氨基转移酶(ALT)是一种易于获得且成本低廉的筛查工具,可用于检测无症状慢性肝病。最近的研究表明,目前接受的健康 ALT 阈值应降低。
在这项回顾性横断面研究中,我们在全国代表性健康队列(来自第四次韩国国家健康和营养检查调查(KNHANES IV)的 n = 3337 名)中确定了 ALT 值的上限阈值。与研究衍生的、性别特异性的 ALT 阈值相比,目前使用的 ALT 阈值(无论性别如何,均为 40 IU/L)检测患有慢性肝病风险的个体的敏感性和特异性在 27913 名健康检查参与者中进行了比较。
在健康体重、代谢正常、无肝病的 KNHANES 参与者中,ALT 的第 95 百分位数水平为男性 34 IU/L,女性 25 IU/L。在目前使用的阈值下,健康检查参与者中 ALT 升高的患病率为 11.0%,而使用研究衍生的、性别特异性的阈值则升高至 22.6%。在新 ALT 阈值下,另外定义为 ALT 水平升高的人群中,有 65.7%存在慢性肝病风险。使用新阈值检测慢性肝病风险个体的敏感性从 18%提高到 33%,但特异性(从 96%降至 88%)存在折衷。
建议降低目前的 ALT 阈值,以更好地识别慢性肝病风险个体。